Results 161 to 170 of about 29,547 (250)

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1701-1721, June 2026.
ABSTRACT Intrahepatic cholangiocarcinoma (iCCA) ranks as the second most common primary liver cancer, compared to about 20% of cases. Its global incidence has climbed over the past four decades, yet early detection remains indefinable due to its asymptomatic nature. Five‐year survival rate of approximately is under 10%.
Yaqoob Muhammad, YuZhu Jin, Kai Luo, He Bai, Xudong Zhang, Xu Sun, Zahoor Maheen, Ali Tanveer, Saeed Muddasar Muhammad, Jialin Qu, Guixin Zhang   +10 more
wiley   +1 more source

Immune Evasion of Helicobacter pylori and Extra‐Gastric Cancer Risk

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1722-1742, June 2026.
ABSTRACT Helicobacter pylori (H. pylori) is a group 1 gastric carcinogen that plays a significant role in extra‐gastric digestive system cancers. H. pylori disrupts host cell homeostasis through expression of virulence factors leading to immune evasion as well as persistent gastric mucosal colonization. H. pylori infection has been shown to play a role
Evren Doruk Engin, Ayse Basak Engin, Atilla Engin   +2 more
wiley   +1 more source

Intrahepatic cholangiocarcinoma: the equity gap in one of the most lethal cancers. [PDF]

J Gastrointest Oncol
Oyenuga M, Gbolahan OB.
europepmc   +1 more source

Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta‐Analysis

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aims Primary sclerosing cholangitis (PSC) is an immune‐mediated cholestatic liver disease. Liver transplantation (LT) remains the only definitive treatment for patients with advanced disease. However, recurrence of PSC (rPSC) after LT is still a significant clinical challenge.
Isabelle Castro Vitor, Milena Ramos Tomé, Wellgner Fernandes Oliveira Amador, Igor Boechat Silveira, Marina de Assis Bezerra Cavalcanti Leite, Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Yohanna Idsabella Rossi, Guilherme Grossi Lopes Cançado, Rodrigo Vieira Motta   +10 more
wiley   +1 more source

Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy. [PDF]

Clin Cancer Res
Abi Jaoude J, Lau A, Yuan Y, Meimoun NS, De B, Liao K, Kouzy R, Nieves-Jimenez HR, Poenisch F, Balter PA, Brock KK, Sawakuchi GO, Vauthey JN, Tzeng CD, Shamsutdinova D, Lazar AJ, Chatterjee D, Holliday EB, Smith GL, Minsky BD, Das P, Koong AC, Lee SS, Tran Cao HS, Javle M, Kwong L, Koay EJ, Ludmir EB.   +27 more
europepmc   +1 more source

Intrahepatic Cholangiocarcinoma [PDF]

, 2018
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi   +6 more
openaire   +2 more sources

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How? [PDF]

J Gastrointest Cancer
Barsch M, Dopfer EP, Schultheis AM, Quante M.   +3 more
europepmc   +1 more source

Prognostic implications of tumour number in intrahepatic cholangiocarcinoma. [PDF]

JHEP Rep
Chan BL, Li Y, Kim Y, Wong AC, Yiu DC, Chan LL, Chu CM, Yoo C, Sun HC, Chan SL.   +9 more
europepmc   +1 more source

B7-H3 CAR T cells eradicate intrahepatic cholangiocarcinoma and induce durable response. [PDF]

J Exp Clin Cancer Res
Arya S, Ventin M, Cattaneo G, Nebbia M, Sanatkar SA, Martin C, Jia J, Kim B, Bailey CA, Bardeesy NM, Ting DT, Deshpande V, Wang X, Ryeom S, Ferrone S, Ferrone CR.   +15 more
europepmc   +1 more source

Case Report: Intrahepatic cholangiocarcinoma masquerading as a giant hepatic cyst. [PDF]

Front Oncol
Tian Z, Rao J, Zhang D, Cheng J, Yang X, Zhao Y, Yu B, He Z, Zhu C, Leng K, Fu N.   +10 more
europepmc   +1 more source